8565010
Germaine™ Laboratories BioSign™ Flu A/B Kit
An In vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Content And Storage
2°C to 30°C
Clia Complexity
Waived (Nasal Swab)
Includes
Positive and Negative Control Swabs
CE Marker
Yes
Detectable Analytes
Influenza A and B
Related Products
Description
- Differentiates between Influenza Type A & B, on a single test device Produces results in 10 to 15 minutes Each test device includes built-in controls Each kit comes with external controls Meets FDA performance criteria for influenza tests stated in code 21 CFR 866.3328 CLIA Complexity: Moderate complexity when used with nasal wash/aspirate samples CLIA Waived when used with nasal and nasopharyngeal swabs
Compare Similar Items
Show Difference
Content And Storage: 2°C to 30°C
Clia Complexity: Waived (Nasal Swab)
Includes: Positive and Negative Control Swabs
CE Marker: Yes
Detectable Analytes: Influenza A and B
Content And Storage:
2°C to 30°C
Clia Complexity:
Waived (Nasal Swab)
Includes:
Positive and Negative Control Swabs
CE Marker:
Yes
Detectable Analytes:
Influenza A and B
Content And Storage: __
Clia Complexity: __
Includes: __
CE Marker: __
Detectable Analytes: __
Content And Storage:
__
Clia Complexity:
__
Includes:
__
CE Marker:
__
Detectable Analytes:
__
Content And Storage: __
Clia Complexity: __
Includes: __
CE Marker: __
Detectable Analytes: __
Content And Storage:
__
Clia Complexity:
__
Includes:
__
CE Marker:
__
Detectable Analytes:
__
Content And Storage: __
Clia Complexity: __
Includes: __
CE Marker: __
Detectable Analytes: __
Content And Storage:
__
Clia Complexity:
__
Includes:
__
CE Marker:
__
Detectable Analytes:
__